AbbVie has broken ground on a $223 million expansion of its Singapore manufacturing facility. The project is expected to create more than 100 new jobs and bolster AbbVie's global biologics manufacturing capacity, the company said in a press release. The new investment is pegged to add 24,000 liters of biologics drug-substance capacity. Source: Fierce Pharma 26/1/2024